To determine the clinical significance of OPN in SCLC, we explored the relationship between the OPN expression level and clinical stage of 168 subjects, discovering that increased expression of OPN in stage II patients remained statistically significant relative to stage I patients in this analysis (P<0.05; Figure 4A). This evidence concerns the gene SPP1 and small cell lung carcinoma.